Beneficial Recognition of Glucose Variability for Adequate Lifestyle by Continuous Glucose Monitoring (CGM)-Reference-Cited by-同舟云学术

Beneficial Recognition of Glucose Variability for Adequate Lifestyle by Continuous Glucose Monitoring (CGM)

Published:2024-04-12 Issue:2 Volume:7 Page:88-93
ISSN:2582-0370
Container-title:Asploro Journal of Biomedical and Clinical Case Reports
language:en
Short-container-title:Asp Biomed Clin Case Rep

Author:

Kawahito Atsuko¹,Bando Hiroshi²^ORCID,Kato Yoshinobu¹,Yamashita Hisako¹,Kato Yoshikane¹

Affiliation:

1. Kanaiso Hospital, Tokushima, Japan

2. Kanaiso Hospital, Tokushima, Japan; Japan low carbohydrate diet promotion association (JLCDPA), Kyoto, Japan; Medical Research/Tokushima University, Tokushima, Japan

Abstract

Recently, actual changes in blood glucose can be measured by continuous glucose monitoring (CGM) using FreeStyle Libre. The case involves a 67-year-old male patient with type 2 diabetes (T2D) treated with Multiple Daily Insulin (MDI) therapy, who underwent CGM. Analysis of the CGM data revealed that hyperglycemia resulted from increased carbohydrate intake and irregular meal timings and quantities. The estimated HbA1c from CGM was 6.6%, whereas the HbA1c value recorded at the outpatient clinic during the same period was 7.3%. The use of CGM applications encourages diabetic patients to be mindful of their carbohydrate intake in daily life, leading to an increased ratio of time spent in the target range (TIR).

Publisher

Asploro Open Access Publications

Reference17 articles.

1. Gregg EW, Buckley J, Ali MK, Davies J, Flood D, Mehta R, Griffiths B, Lim LL, Manne-Goehler J, Pearson-Stuttard J, Tandon N, Roglic G, Slama S, Shaw JE; Global Health and Population Project on Access to Care for Cardiometabolic Diseases. Improving health outcomes of people with diabetes: target setting for the WHO Global Diabetes Compact. Lancet. 2023 Apr 15;401(10384):1302-12. [PMID: 36931289]

2. American Diabetes Association Professional Practice Committee. Introduction and Methodology: Standards of Care in Diabetes-2024. Diabetes Care. 2024 Jan 1;47(Supplement_1):S1-S4. [PMID: 38078587]

3. Parker ED, Lin J, Mahoney T, Ume N, Yang G, Gabbay RA, ElSayed NA, Bannuru RR. Economic Costs of Diabetes in the U.S. in 2022. Diabetes Care. 2024 Jan 1;47(1):26-43. [PMID: 37909353]

4. Chong K, Chang JK, Chuang LM. Recent advances in the treatment of type 2 diabetes mellitus using new drug therapies. Kaohsiung J Med Sci. 2024 Mar;40(3):212-20. [PMID: 38183334]

5. Jancev M, Vissers TACM, Visseren FLJ, van Bon AC, Serné EH, DeVries JH, de Valk HW, van Sloten TT. Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis. Diabetologia. 2024 May;67(5):798-10. [PMID: 38363342]

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diabetic Elderly with Keeping Less Arteriosclerosis Treated by Imeglimin (Twymeeg);Asploro Journal of Biomedical and Clinical Case Reports;2024-05-28